Overview of Dr. Braunstein
Dr. Lior Braunstein is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. He received his medical degree from Harvard Medical School and has been in practice 6 years. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 6 doctors at Memorial Sloan Kettering Bergen who specialize in Radiation Oncology. He has more than 90 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2012 - 2016
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2011 - 2015
- Brigham and Women's HospitalInternship, Internal Medicine, 2011 - 2012
- Harvard Medical SchoolClass of 2011
Certifications & Licensure
- FL State Medical License 2023 - Present
- NY State Medical License 2016 - 2026
- NJ State Medical License 2016 - 2025
- MA State Medical License 2013 - 2018
- American Board of Radiology Radiation Oncology
Clinical Trials
- The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer Start of enrollment: 2016 May 01
- Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial Start of enrollment: 2016 Feb 01
Roles: Contact
Publications & Presentations
PubMed
- Honing Locoregional Therapy for Breast Cancer: Refinement of Surgical and Radiotherapeutic Management.Pierre Loap, Youlia Kirova, Lior Z Braunstein
International Journal of Radiation Oncology, Biology, Physics. 2024-12-01 - 1 citationsAutomated real-world data integration improves cancer outcome prediction.Justin Jee, Christopher Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra
Nature. 2024-11-06 - Radiation-Associated Secondary Cancer in Patients With Breast Cancer Harboring TP53 Germline Variants.Gustav Y Cederquist, Lillian A Boe, Michael Walsh, Gary M Freedman, Kara N Maxwell
JAMA Oncology. 2024-11-01
Journal Articles
- Accuracy of Magnetic Resonance Imaging–Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant ChemotherapyElizabeth J Sutton, Lior Z Braunstein, Yolanda Bryce, Jill S Gluskin, Pedram Razavi, JAMA Network Open
- Potential Morbidity Reduction with Proton Radiation Therapy for Breast Cancer☆Oren Cahlon, Lior Z Braunstein, ScienceDirect
Press Mentions
- Mutations in BRCA1 and BRCA2 Differentially Affect the Tumor Microenvironment and Response to Checkpoint Blockade ImmunotherapyNovember 16th, 2020
- Cancer Therapy Shapes the Fitness Landscape of Clonal HematopoiesisOctober 26th, 2020
- A Machine Learning Model That Classifies Breast Cancer Pathologic Complete Response on MRI Post-Neoadjuvant ChemotherapyMay 28th, 2020
- Join now to see all
Professional Memberships
- American Society of Radiation Oncology (ASTRO)Member
- Member
- Member
- NRG OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: